| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2003) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | 75046A1XTN |
| Parent Compound: | ALFUZOSIN |
| InChI Key | YTNKWDJILNVLGX-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C19H28ClN5O4 |
| Molecular Weight | 425.92 |
| AlogP | 1.35 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 111.83 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 28.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Adrenergic receptor alpha-1 agonist |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | 16.07 | |
|
Enzyme
Transferase
|
- | - | - | - | 17.82 | |
|
Enzyme
|
- | - | - | - | 16.07 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -26.85--1.86 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Kidney Calculi | 3 | D007669 | ClinicalTrials |
| Ureterolithiasis | 3 | D053039 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 32286 |
| ChEMBL | CHEMBL1723 |
| EPA CompTox | DTXSID3045514 |
| FDA SRS | 75046A1XTN |
| Guide to Pharmacology | 7109 |
| KEGG | D07124 |
| PubChem | 25137863 |
| SureChEMBL | SCHEMBL179910 |
| ZINC | ZINC01843099 |